Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : APPI - Advanced Plant Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Clarke who wrote (996)	7/30/1999 1:14:00 PM
From: Jim Mills	Respond to of 1263

This is old new........I just don't understand one thing..... Why can't I be a part of the case study???? -------------------------------------------------- Advanced Plant Pharmaceuticals, Inc. (New York, NY; 212-964-5863), announced that the company has filed a patent application for Leuknil, a new breakthrough drug targeted to treat Leukemia. Case studies conducted on people who used Leuknil showed that the drug "greatly improved white blood cell counts". In vitro studies conducted by a major pharma-ceutical company, Leuknil has, among other things, been found to also destroy general cancer cells. -------------------------------------------------- "Greatly improved white blood cell counts"...... Let me be the judge of that. I see my white blood cell count go up and down like a yo-yo every three months.... 40,000 to 35,000 back to 39,000.... Then down to 28,000 and back up to 36,000..... As of three months ago it was at 26,000...... Come on APPI....... LET ME IN ON IT! I have a doctor's appointment in two weeks for a CBC..... I'll use it for the next three months and see what happens (PLEASE) Jim...... jimsgtx@aol.com